Industries > Pharma > Global Anaesthesia Drugs Market 2018-2028

Global Anaesthesia Drugs Market 2018-2028

Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia

PUBLISHED: 28 February 2018
PAGES: 172
PRODUCT CODE: PHA0289

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0289 Categories: , , Tags: ,

The global anaesthesia drugs market is expected to reach $10.5bn in 2022 and is estimated to grow at a CAGR of 3.6% from 2017 to 2028. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market and is also projected to grow at the highest CAGR during the forecast period owing to its large application in surgeries, less adverse effects, and high adoption rate.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 172-page report you will receive 104 tables and 72 figures– all unavailable elsewhere. 

The 172-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Anaesthesia Drugs Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2028 for the market segmented by type:
• Local Anaesthesia Drugs
• General Anaesthesia Drugs

• This report shows forecasts to 2028 for the market segmented by route of administration:
• Inhalation Anaesthesia Drugs 
• Intravenous Anaesthesia Drugs
• Topical Anaesthesia Drugs

• Our analyses show individual revenue forecasts to 2028 for these regional and national markets:
• North America: US and Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa

Each regional and national market is further segmented by type and route of administration.

Global Anaesthesia Drugs Market 2018-2028

• This report discusses the leading drugs of the global anaesthesia drugs market

• This report profiles the leading companies in the global anaesthesia drugs industry:
• Baxter International, Inc.
• AbbVie
• PAION AG
• Pfizer
• Hameln Pharmaceuticals
• AstraZeneca
• Fresenius Kabi
• Maruishi Pharmaceuticals
• Pacira Pharmaceuticals, Inc

• This report discusses promising drug candidates which are under development for the Anaesthesia drugs market.

• Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain’s study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions. 

Buy our report today Global Anaesthesia Drugs Market 2018-2028: Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2018-2028


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category